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Abstract: In this paper, we report on an in-house developed electronic nose (E-nose) for use with 
breath analysis. The unit consists of an array of 10 micro-electro-mechanical systems (MEMS) metal 
oxide (MOX) gas sensors produced by seven manufacturers. Breath sampling of end-tidal breath is 
achieved using a heated sample tube, capable of monitoring sampling-related parameters, such as 
carbon dioxide (CO2), humidity, and temperature. A simple mobile app was developed to receive 
real-time data from the device, using Wi-Fi communication. The system has been tested using 
chemical standards and exhaled breath samples from healthy volunteers, before and after taking a 
peppermint capsule. Results from chemical testing indicate that we can separate chemical standards 
(acetone, isopropanol and 1-propanol) and different concentrations of isobutylene. The analysis of 
exhaled breath samples demonstrate that we can distinguish between pre- and post-consumption 
of peppermint capsules; area under the curve (AUC): 0.81, sensitivity: 0.83 (0.59–0.96), specificity: 
0.72 (0.47–0.90), p-value: <0.001. The functionality of the developed device has been demonstrated 
with the testing of chemical standards and a simplified breath study using peppermint capsules. It 
is our intention to deploy this system in a UK hospital in an upcoming breath research study. 
Keywords: Breath analysis; electronic nose (E-nose); Internet-of-Things (IoT) 
 
1. Introduction 
The diagnostic potential of breath was first utilised by ancient Greek physicians who understood 
that distinct odours and aromas could be related to specific diseases [1]. In recent years, applications 
of breath analysis have focused on the non-invasive detection of volatile organic compounds (VOCs), 
using different technological platforms. It has been suggested that there are over 3000 VOCs in 
human breath that are a combination of by-products of normal metabolic activity and, in some cases, 
specifically associated with a disease [2]. Changes in VOC composition or concentrations serve as 
potential biomarkers for the detection and monitoring of disease, such as chronic obstructive 
pulmonary disease (COPD) [3], colorectal cancer [4], and many more [5]. Gas chromatography-mass 
spectrometry (GC-MS) is generally considered the “gold standard” for breath research and is the 
most commonly used technique [6]. GC-MS is considered an offline method because samples need to 
be collected (and potentially stored) onto, for example, thermal desorption (TD) tubes or sampling 
bags, prior to analysis. Other commonly used technologies include proton-transfer-reaction mass-
spectrometry (PTR-MS) and selected-ion flow tube mass spectrometry (SIFT-MS) [5]. These 
technologies are on-line methods (suitable for real-time analysis) and have been used for both disease 
diagnosis studies [7] and monitoring pharmacokinetics effects [8]. Although these analytical 
platforms are highly reproducible and accurate, they are very expensive, time-consuming, and lack 
portability. 
To fully utilise the diagnostic potential of exhaled breath, Hunter and Dweik [9] argued that its 
application must be extended beyond laboratories and pilot studies to standard clinical practice and 
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at home. The latter requires a compact, personal and portable diagnostic device, capable of sampling 
and analysing the breath of an individual at any time or place. The authors referred to this as a “smart 
breath healthy diagnostic system” (SBHDS). Since this concept was first proposed in 2008, the 
technological revolution of Internet-of-things (IoT) has invigorated the demand for smarter sensor 
solutions. This also applies to the medical and healthcare domain (so-called IoMT: internet of medical 
things), which seeks to integrate medical devices into IoT networks. Personalised tools for health 
monitoring could reduce the overall costs of care and bring numerous benefits to health professionals 
and patients [10]. Utilising the computing power of smartphones, these sensor systems could analyse 
and transmit collected data from a patient to a hospital cloud computing-based framework. We 
believe that personalised breath analysis devices for non-invasive diagnosis and/or monitoring of 
disease have potential for integration into this future IoMT-framework. However, the currently used 
technologies are unable to fulfil the requirements of such a device. 
While no single VOC analysis technology can provide the complete diagnosis of an individual, 
the electronic nose (E-nose) could be considered a good option as it has significant advantages. These 
include low-cost, low-power (compared to GC-MS), user-friendliness, and portability. An ‘E-nose’ 
describes an instrument consisting of an array of cross-reactive gas sensors, coupled with pattern 
recognition software. It relies on each sensor in the array being different and therefore its response to 
an odour being unique within the array. The pattern recognition software then learns the sensor 
responses associated with a specific odour source [11]. This operating principle attempts to mimic 
the function of biological olfactory receptors by detecting a complex pattern, instead of measuring 
the individual constituents of a mixture. Gas sensors suitable for E-noses can be broadly divided into 
four main types, namely resistive, catalytic, optical, and electrochemical [12]. Resistive gas sensors 
are often based on semiconductor metal oxides that have been widely used for E-noses, due to their 
fast response/recovery time, low-cost, and sensitivity to a wide range of target gases [13]. In recent 
years, the application of micro-electro-mechanical systems (MEMS) technology has allowed metal 
oxide (MOX) gas sensors to dramatically reduce in size and power consumption. Mass-production 
has allowed these sensors to be produced at even lower cost. These developments provide new 
opportunities in medical diagnostic applications, such as SBHDS-inspired E-noses. 
In a 2018 review paper [14] regarding the applications of E-noses, at least 50 papers related to 
non-invasive detection of human diseases; 27 of which analysed exhaled breath. The commercial E-
nose instrument most frequently used (14/27) for breath was Cyranose 320 (Sensigent, Baldwin Park, 
CA, USA). This E-nose contains an array of 32 carbon black polymer composite (CBPC) sensors. The 
advantage of CBPC sensors (compared to MOX) is that they do not require high temperature 
operation and therefore have lower power consumption. The disadvantage of this sensing technology 
is that they demonstrate poor repeatability and reproducibility, due to the random nature of the 
polymer, and have a relatively short sensor life, compared to MOX sensors [15]. Other sensor 
technologies included in the review were quartz crystal microbalance (QMB), nitric oxide sensor 
(NOS), gold nanoparticle (GNP), and carbon nanotubes (CNT). Only three papers in the review used 
E-noses with MOX sensors [16–18]. In a different review paper, regarding the use of E-nose 
technology for the diagnosis of digestive and respiratory diseases using exhaled breath, MOX sensor-
based E-noses are similarly under-represented (four of 23 reviewed papers) [19]. These reviews 
demonstrate that MOX sensors are currently under-utilised in E-nose applications for exhaled breath 
research. While new prototype MOX-based E-noses are currently being developed for diagnostic 
purposes using exhaled breath [20], these often use custom sensors or traditional commercial MOX 
sensors/E-noses, which have been available for many years [21]. The latest generation of 
commercially available MEMS MOX gas sensors have not been sufficiently evaluated for this 
purpose. 
Some researchers have used a selection of these sensors in devices for air quality monitoring 
purposes [22,23], but applications in breath research are limited. The breath E-nose developed by 
Jaeschke et al. [24] uses many of the most relevant commercial gas sensors currently available. 
However, this unit focuses on a modular approach with three exchangeable sensing compartments 
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and has not been tested using exhaled breath samples. This provides an opportunity to utilise MEMS 
MOX gas sensors and existing IoT platforms to develop a new generation of breath analysis E-noses. 
In our previous work [25], we developed a E-nose which was referred to as WOLF (Warwick 
OLFaction). This system utilised 13 gas sensors and multiple sensor technologies (10 electrochemical, 
two optical and one photo-ionisation detector) and was intended for head-space gas analysis. In this 
work, we report on the development of the latest in-house built WOLF E-nose, designed specifically 
for breath analysis: WOLF Breath E-nose. 
2. Materials and Methods 
2.1. Breath Sampling 
The developed unit comprises of 2 sub-systems: breath sampling and breath analysis. The breath 
sampling system is made up of a 16 cm long, 2 cm diameter, aluminium tube with 3D printed tube 
connectors on either end. These components serve as an interface between the sampling tube and the 
enclosure and were printed on a Form 2 printer using F2GPWH-04 material (Formlabs, Somerville, 
MA, USA). The front-end connector also acts as a holder for disposable one-way valve mouthpieces 
(6020-1, Medacx, Hayling Island, UK). The back-end connector was designed with an opening to 
embed a sensor module (SCD30, Sensirion, Stäfa, Switzerland). The assembly of these components is 
shown in Figure 1, designed using SolidWorks (ver. 2018, Dassault Systèmes, Vélizy-Villacoublay, 
France). The sensor module was fitted at the end of the sampling tube to monitor sampling-related 
parameters, such as carbon dioxide (CO2), humidity, and temperature. Tracking these parameters 
allows the subject (at home) or operator (in a clinical setting) to check the quality and repeatability of 
samples. 
 
Figure 1. 3D model of sampling tube components: (a) One-way mouthpiece; (b) Front-end tube 
connector; (c) Sampling tube; (d) Back-end tube connector; (e) Sensor module. 
The sampling tube has a volume of approximately 50 mL and can be heated to body temperature 
(35–37 °C) using a low-cost digital thermostat and heater relay module (W1209, HiLetgo, Shenzhen, 
China). The heater relay is connected to nichrome (NiCr) wire, which is coiled around the sampling 
tube. The tube was then wrapped in high temperature resistant Kapton tape (436-2778, RS, Corby, 
UK) and silicone thermal interface sheets (446-493, RS, Corby, UK) to provide some insulation. The 
heating procedure is initiated at start-up and takes around 10 min. Heating the sampling tube avoids 
condensation from forming inside, which could lead to cross-contamination from previous samples. 
The integrated sampling system replicates that of the Bio-VOC breath sampler (C-BIO01, Markes 
Intl., Llantrisant, UK). The Bio-VOC is a commercial breath sampling kit, consisting of an open-ended 
hard plastic sampling tube. It has been used frequently in recent breath analysis studies [26] for the 
sampling of end-tidal breath. This refers to the last portion of exhaled air, which has undergone 
gaseous exchange with blood [27]. As the subject breathes through the tube, air is displaced, which 
separates dead-space gas from end-tidal breath. This displacement principle has been replicated in 
our sampling design. The use of one-way valve mouthpieces and heating the sampling tube further 
improve on the design concept of the Bio-VOC. 
2.2. Breath Analysis 
The breath analysis system includes a custom PCB and sensor chamber. The PCB was designed 
using Altium Designer (ver. 19.1.6, Altium, Chatswood, Australia). The dimensions of the PCB are 
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13 × 16 cm. The design has an 8 × 2.5 cm sensing area, which includes an array of 10 MEMS MOX-
based gas sensors. These include both thick film and thin film sensors and the AlphaSense dual sensor 
is the only true ‘p-type’ material [28]. Both analogue and digital sensors were used. According to the 
respective datasheets, most of the sensors provide ‘total VOC’ (TVOC) readings, which produce a 
single measurement to represent a mixture of VOCs. The total cost of the sensors is around £200. The 
deployed sensors are summarised in Table 1. 
Table 1. Sensors deployed in WOLF Breath E-nose. 
Interface Sensor  Manufacturer Target Gas 
Digital 
CCS811 ams TVOC 
SGP30 Sensirion H2, ethanol 
BME680 Bosch TVOC 
iAQ-Core C ams TVOC 
ZMOD4410 IDT TVOC 
Analog 
MiCS-6814 SGX NH3, reducing, oxidising 
Dual Sensor AlphaSense Reducing and oxidising 
TGS-8100 Figaro TVOC 
TGS-2620 Figaro TVOC 
AS-MLV-P2 ams Reducing and CO 
The sensing area is enclosed by a 3D printed sensor chamber (F2GPWH-04/Form 2, Formlabs, 
Somerville, MA, USA), with dimensions of 4 × 9.5 × 1.8 cm. The chamber was sealed to the PCB using 
an O-ring and the compartment volume is around 25 mL (excluding sensors). A miniature pump 
(PMM1031-NMP015, KNF, Witney, UK) was used to create a negative pressure system, which pulls 
gas through the sensor chamber. There is a 3-way valve (ETO-3-12, Clippard, Cincinnati, OH, USA) 
between the sampling tube and sensor chamber. This creates 2 flow-paths to the sensor chamber: 
ambient air (from the environment) or exhaled breath (from the sampling tube). Push-fit connectors 
and 1/8” PTFE tubing (06605-27, Cole-Parmer, St Neots, UK) were used to create the internal 
connections (e.g., valve to sensor chamber). The pump runs continuously (flow rate set to 500 
mL/min) and pulls ambient air through the sensor chamber, when the device is in an idle state. The 
flow rate of the pump is controlled using a simple digital-to-analogue converter (DAC) drive circuit. 
There is no flow feedback, but the flow rate was measured using a flowmeter (7000 Flowmeter, 
Ellutia, Ely, UK) and voltage set to the desired flow rate. The switching of the valve is also controlled 
using a DAC drive circuit. When sampling is activated, using the LED-push button on the front-panel 
of the unit, the valve is triggered to switch the flow-path to that from the sampling tube. The internal 
layout of the components was modelled and arranged in SolidWorks prior to manufacture, as shown 
in Figure 2. 
 
Figure 2. Internal layout of WOLF Breath E-nose components: (a) Sampling tube; (b) Sensor module; 
(c) Back plate with USB, exhaust, on/off button and DC power jack; (d) 3-way valve; (e) Heater relay 
module; (f) Pump; (g) Custom PCB; (h) Sensor chamber; (i) Indicator LEDs; (j) Sampling button. 
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An internal system view of the WOLF Breath E-nose is shown in Figure 3. The red and blue 
arrows indicate the different flow-paths through the device. The dimensions of the unit are 7 × 16 × 
23 cm and weighs less than 1 kg. An external view of the unit is shown in Figure 4. 
 
Figure 3. Internal system view of the WOLF Breath E-nose. 
 
Figure 4. WOLF Breath E-nose: (a) Mouthpiece holder; (b) LED status indicators; (c) Sampling tube 
temperature indicator; (d) Sampling button. 
The unit can be controlled from a laptop, via wired USB, or using Wi-Fi through a simple mobile 
app that was developed using Blynk. This app provides a free IoT platform for Android or iOS and 
is compatible with commonly used IoT hardware, such as Arduino, Raspberry Pi, ESP8266 and 
ESP32. The ESP32 (Espressif Systems, Shanghai, China) was used as the microcontroller for our 
system, because it is a low-cost, low-power chip with integrated Wi-Fi and Bluetooth communication 
capabilities. The custom ‘WOLF Breath E-Nose’ app includes 2 tabs: sampling and analysis, as shown 
in Figure 5. The sampling tab includes 3 input fields to include details such as study name, subject 
ID and sample name. In addition to this, status indicators from the front-panel of the device are 
shown, as well as real-time readings of CO2, temperature and humidity from the SCD30 sensor. The 
parameters can be selected and plotted on the graph, as shown with CO2 in Figure 5 (left). The 
analysis tab shows the real-time readings from the gas sensor array. Individual or multiple outputs 
can be selected and plotted on the graph, as shown with CCS811 and BME680 in Figure 5 (middle). 
The other readings can be seen by scrolling down, as shown in Figure 5 (right). The sampling rate of 
the sensor data was set to 1 sample per second. 
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Figure 5. WOLF Breath E-nose Blynk app; (left) Sampling tab; (middle) Analysis tab with real-time 
output graph; (right) Analysis tab with all sensor readings. 
2.3. Electronic Design 
The operating principle of MOX sensors is based on a reduction-oxidation (redox) reaction. In 
‘clean’ air, oxygen is absorbed onto the gas-sensitive layer of the sensor (e.g., tin oxide). When 
exposed to a reducing or oxidising gas, the oxygen reacts to the target gas, which changes the 
conductivity of the sensitive layer, resulting in a change in current [29]. The applied voltage is fixed, 
to measure the change in resistance to characterise the sensor response. Traditionally, the limitations 
of MOX gas sensors relate to high power consumption and temporal drift [30,31]. The emergence of 
MEMS-technology MOX sensors has led to further miniaturisation of sensing chips and heater 
resistors, which has drastically reduced power consumption. In general, thick film MOX sensors are 
more stable than MEMS (thin film) devices, however MEMS sensors have faster response times [32]. 
To further reduce power consumption, duty cycling using two temperature pulsing can be used. This 
involves switching between a higher and lower temperature, to reduce baseline drift, decrease 
response time and power [33]. For this application, a heating phase of 150 ms was implemented for 
the analogue MEMS MOX gas sensors. 
The power system of the E-nose is currently based around the input from a 12 V AC/DC mains 
power supply unit (709-GEM30I12-P1J, Mouser, High Wycombe, UK). The system was designed 
around 12 V, because this is the required voltage for the valve and heater relay module. However, in 
future, this device may be re-configured to be battery-operated. In addition to the improved sensor 
stability, the possibility of utilising duty-cycle mode is likely to be beneficial for reducing power 
consumption when battery-powered. 
The schematic shown in Figure 6 shows a simplified circuit diagram of sensor and heater drive 
circuits for analogue MOX sensors. The 12-bit resolution DAC in the sensor drive circuit dictates the 
sensor voltage (using a constant voltage configuration) and the previously referred to duty-cycle. The 
second stage of the sensor drive circuit removes the offset of the voltage bias and amplifies the sensor 
response, in this case with a gain of 2.2. The sensor output is then read using a 16-bit resolution 
analogue-to-digital converter (ADC). The heater drive circuit is controlled by a DAC and provides a 
fixed heater voltage to the heater of the gas sensor. The heater resistance of the sensor can be 
calculated by measuring the voltage drop, using an ADC, across the heater load resistor. Table 2 
provides a summary of the sensor and heater voltages and resistances for deployed analogue gas 
sensors. The values in Table 2 relating to sensor resistances represent the real resistances of the 
sensors used in the unit. The heater resistances are those provided by the manufacturer. The values 
of the sensor and heater load resistors were optimised to allow for the measurement of the widest 
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range of RS/R0, according to their respective datasheets, where RS is the resistance of the sensor 
depending on the concentration of target gas(es) and R0 is the resistance of the sensor at ambient air. 
 
Figure 6. Simplified circuit diagram of sensor and heater drive circuits for analogue MOX sensors. 
Table 2. Sensor and heater voltages and resistances for analogue VOC sensors. 
Sensor Sensor Voltage Sensor Resistance Heater Voltage Heater Resistance 
MiCS-6814 * 5.0 V 180/45/650 kΩ 2.4/1.7/2.2 V 72/66/72 Ω 
Dual Sensor 5.0 V 500 kΩ 5.0 V 50–500 kΩ 
TGS-8100 3.0 V 45 kΩ 1.8 V 110 Ω 
TGS-2620 5.0 V 20 kΩ 5.0 V 83 Ω 
AS-MLV-P2 5.0 V 500 kΩ 3.0 V 50–500 kΩ 
* MiCS-6814 has 3 VOC outputs: reducing gases, oxidising gases, NH3. 
2.4. Chemical Testing 
The WOLF Breath E-nose was tested using chemical standards to calibrate the device and ensure 
that all sensors were functioning correctly. This is a standard approach used to calibrate gas sensor 
arrays [25]. For these tests, it is necessary to generate headspace gas from 3 chemicals; in this case, 
acetone, isopropanol and 1-propanol with 99% purity (Sigma-Aldrich, Dorset, UK). The chemicals 
were diluted using deionised water to concentrations of 0.1% acetone, 0.1% 1-propanol and 0.05% 
isopropanol. A set of 6 headspace vials were prepared for each chemical, with 1 mL in each. These 
were heated for 10 min at 40 ± 0.1 °C in a heater block (DB-2D Dri-Block, Techne/Cole-Parmer, Stone, 
UK). For testing, the vials were connected to the sensor chamber using PTFE tubing and the 
headspace gas was pulled into the sensor chamber using the miniature pump. The sequence of tested 
solutions was acetone, 1-propanol, isopropanol, [repeat] to mitigate against effects of sensor drift. 
After pulling the headspace gas into the chamber, the sample was disconnected to allow ambient air 
into the chamber. A period of 5–10 min was sufficient for sensor responses to return to baseline levels 
between each test. Principal component analysis (PCA) was conducted on the results. PCA is an 
unsupervised linear method, which reduces the dimensionality of the data by selecting a small 
number of linearly uncorrelated principal components (PC) that explain the majority of the variation 
in the data [34]. For PCA analysis, feature extraction was conducted using the difference model, 
whereby the maximum gas sensor response is subtracted from the stable baseline value, prior to the 
response [35]. 
In addition to these tests, the sensor array was evaluated using a gas rig to test the response to a 
single chemical, isobutylene, at different concentrations. A gas cylinder with a nominal concentration 
of 50 ppm was diluted with zero air from a zero-air generator (HPZA-7000-220, Parker, Warwick, 
UK) to concentrations of 2, 4, 6, 8, and 10 ppm using a custom mass flow-controlled gas mixing 
system. The total flow rate of the diluted gas was set to 300 mL/min and humidity was added using 
a water bubbler (around 60% RH, measured using the BME680 gas sensor). The test started with 1 
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hour of zero air, followed by 30-min of increasing concentration steps, with 30-min of zero air 
between each step. The experimental set-up for the gas rig testing is shown in Figure 7. 
 
Figure 7. Experimental gas-rig set-up for testing isobutylene concentrations. 
2.5. Exhaled Breath Testing 
To simulate a control vs. disease group case-control study, a peppermint breath test was 
conducted. Ethical approval was obtained from local research ethics committee (BSREC reference: 
REGO-2018-2168). A total of 18 subjects were recruited for these tests. All subjects were healthy (self-
reported), male, and between the ages of 21–30 (mean age of 25.4 years and standard deviation 1.8). 
Previous breath analysis studies have demonstrated that factors such as age, sex, weight, lifestyle and 
medication can influence breath composition [36]. To minimise the effects of these confounding 
factors, the recruited subjects were of the same sex and age (young adults, defined as ages 18–35 
years). 
Subjects provided breath samples pre- and post-consumption of a 200 mg peppermint oil 
capsule (2851512, Boots, Nottingham, UK). The intended application of these capsules is to support 
a healthy digestive system and aid the normal functioning of the digestive tract [37]. However, the 
consumption of peppermint oil also produces a well-defined, but temporary, change in the breath 
profile of an individual. As the ingested peppermint oil capsule dissolves, it releases volatile aroma 
compounds (e.g., menthol), which can be detected in breath for up to 10 hours [38]. Investigating the 
‘wash-out’ profile of peppermint oil in breath has been proposed as a method of standardising breath 
analysis methods by benchmarking analysis techniques. Some work relating to this has already been 
published using GC-MS and PTR-MS technologies [38,39]. To the best of our knowledge, this is the 
first peppermint breath study conducted using E-nose technology. For this study, we used the 
standardised intervention of peppermint oil capsules to change the breath composition of the 
‘peppermint’ breath samples to simulate a ‘disease’ group. The menthol intensity has been observed 
to peak after 30–45 min [39]. The sampling interval between ‘baseline’ and ‘peppermint’ samples was 
around 45-min for the conducted experiments. 
3. Results 
3.1. Chemical Testing 
The PCA results are shown in Figure 8 (left) as a score plot. Each sample is presented by a single 
point, which demonstrates the relations (similarity) between all samples. Points that lie close to each 
other have similar properties while points that are further away have different properties [40]. This 
result demonstrates good separation between the three chemicals with no overlap. The principal 
components PC1 and PC2 account for over 90% of the variance, which is considered a robust result 
[41]. This indicates that the WOLF Breath E-nose has some selectivity at distinguishing between 
individual chemicals. 
The results from the isobutylene concentration gas rig tests are presented as a radar plot of 
normalised features in Figure 8 (right). The radar plot demonstrates that the sensors consistently 
responded to the concentration steps. Examples of the gas sensor responses from the SGP30 and TGS-
2620 sensors are shown in Figure 9. 
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Figure 8. Testing of chemical standards; (left) PCA results; (right) Isobutylene concentration steps 
radar plot of normalised features. 
 
Figure 9. SGP30 and TGS-2620 gas sensor responses to increasing concentrations of isobutylene. 
3.2. Volunteer Testing 
Prior to conducting the peppermint breath tests, the device was turned on and left to stabilise in 
ambient air for over 1 h. A minimum start-up time of 10–15 min is necessary to allow the heater relay 
to heat the sampling tube to body temperature. Furthermore, the gas sensors need some time to reach 
operating temperatures and stable baseline output readings. The warm-up and baseline stabilisation 
output response is shown in Figure 10. 
 
Figure 10. Warm-up and baseline stabilisation output response. 
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For our volunteer experiments, subjects did not need to exhale until their lungs were as empty 
as possible. Instead, only four seconds of exhaled breath were required. Subjects were asked to inhale 
for four seconds, and then exhale normally into the device for around four seconds. This procedure 
can improve the reproducibility of sampling, as shown in Figure 11. These readings are from the 
sensor module, embedded in the back-end connector of the sampling tube. Figure 11 demonstrates 
that using this standardised sampling procedure produces very consistent and reproducible outputs 
for commonly used sampling parameters, such as CO2 and humidity. This procedure should 
therefore minimise sampling-related variability in exhaled breath composition. A typical sensor array 
output response to exhaled breath, from the same subject, is shown in Figure 12. 
 
Figure 11. Breath sampling reproducibility using carbon dioxide and humidity sensor readings. 
 
Figure 12. Typical output response to exhaled breath. 
Most applications of exhaled breath research aim to discriminate between disease states. These 
applications require classification analysis to distinguish between groups and aim to build and train 
a model that can be used as a diagnostic tool. In our previous work, a standard classification analysis 
pipeline has been developed and applied to urinary and breath VOC studies using E-nose technology 
to investigate diabetes and inflammatory bowel disease (IBD) [42,43]. The same analysis pipeline was 
applied to this simulated case-control study between baseline (pre-consumption) and peppermint 
(post-consumption) exhaled breath samples. Classification results are expressed as a receiver 
operating characteristic (ROC) curve, as shown in Figure 13 (left). In ROC curves, the true positive 
rate (sensitivity) is plotted as a function of the false positive rate (1-specificity) [44]. The area under 
the ROC curve (AUC) is a measure of how well parameters can distinguish between groups [45]. An 
area of 1.0 represents a perfect test whereas an area of around 0.5 has no discriminatory power. Good 
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separation would result in an AUC of around 0.7 or higher [46]. The classification results were AUC: 
0.81, sensitivity: 0.83 (0.59–0.96), specificity: 0.72 (0.47–0.90), p-value: <0.001. These results were 
achieved using the Support Vector Machine (SVM) classifier. This classifier has been used in E-nose 
breath studies investigating cancer [47,48], pneumonia [49], and kidney disease [50]. When 
classification is performed, a p-value can be calculated to infer whether the null hypothesis is true, 
i.e. no differences exist between groups. Traditionally, a p-value smaller than 0.05 is used as an 
appropriate threshold to reject the null hypothesis [5]. A radar plot of normalised features is shown 
in Figure 13 (right). This demonstrates consistent differences in the sensor response between baseline 
and peppermint samples. 
  
Figure 13. Baseline vs peppermint exhaled breath samples; (left) ROC curve; (right) Peppermint 
breath test radar plot of normalised features. 
4. Discussion 
Testing of chemical standards, to discriminate between acetone, isopropanol and 1-propanol, 
and concentration steps of isobutylene, were conducted to evaluate the functionality of the developed 
unit. The results indicate that the WOLF Breath E-nose shows selectivity to distinguish between these 
chemicals. Different concentrations of isobutylene were associated with changes in the sensor array 
response. The concentration steps for the gas rig testing was 2 ppm. Since many exhaled VOCs are 
observed in low ppb range, further testing is required to determine the sensitivity of the gas sensors 
at lower concentrations. It should however be reiterated that the E-nose approach relies mainly on 
the cross-sensitivity of the gas sensors to interpret a complex sensor response pattern, as opposed to 
the individual sensor sensitivities to specific compounds. 
The repeatability testing demonstrates that the sampling procedure can produce very consistent 
outputs. These readings can be used to monitor the quality and consistency of collected samples. For 
example, if multiple breath samples are to be collected from the same individual, the CO2 output 
characteristics should be similar for each sample. If outliers or incorrect breathing (e.g., forced 
exhalation) is identified, the sample should be excluded or repeated. Volunteer testing of the system 
indicates that the unit is simple to use, for both the subject and operator, and comfortable for the 
subject. This sampling approach is non-restrictive and likely to be suitable for sampling vulnerable 
subjects, such as children or the elderly. The results from the peppermint study indicate that the 
WOLF Breath E-nose is capable of detecting the subtle change in breath composition that was induced 
by the consumption of peppermint oil. Restricting recruitment to young adult male subjects provided 
a robust experimental design. Future tests will include different age ranges and sexes, to reflect a 
more realistic sample group. Limited dietary control was enforced during the collection of exhaled 
breath samples. Strict dietary protocols and increasing the number of volunteers is likely to further 
improve classification results. 
There are some limitations associated with the developed unit. A drawback of the MOX-based 
gas sensor unit is that there is an inherent variability between sensors, as a result of manufacturing 
processes [51]. To minimise these effects, it may be necessary to screen a large number of the same 
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sensors to choose those with similar characteristics (e.g., sensor resistance at room temperature). 
While this increases development costs per unit, it is likely to be an effective method to reduce sensor 
variability between units. In addition to screening, the circuit design can be utilised to reduce possible 
problems of variability. For example, the heater drive circuit allows the real heater resistance to be 
calculated, which varies for different sensors of the same model. The required heater supply voltage 
can then be set so that the dissipated power is always the same. 
If the proposed unit is intended to be used as a personalised breath analysis device, it will be 
necessary to be able to compare the results to other users. A calibration protocol needs to be 
developed to calibrate these devices regularly to evaluate whether the inter-variability between 
devices is acceptable for comparing breath profiles from different individuals. Such a protocol could 
involve benchmarking responses to a mixture of breath-related chemical standards. We have not yet 
evaluated how many times or how regularly the sensor array needs to be calibrated. Long-term 
stability testing of the system needs to be conducted in order to do this (e.g., tracking sensor drift 
over weeks or months). 
Another limitation of MOX gas sensors is that the sensor response is affected by high levels of 
humidity. A strong correlation between changes in relative humidity and MOX sensor responses has 
been demonstrated [52]. However, since this E-nose was designed for applications in breath research, 
samples will inevitably have relatively high humidity levels. This was taken into account during gas 
rig testing by adding humidity using a water bubbler. Moreover, the effects of humidity will be 
relatively constant during the analysis of exhaled breath, since all samples will be associated with 
similar levels of high humidity. 
As briefly discussed previously, sensor drift is also a critical factor for long-term monitoring 
applications of the E-nose. The experiments presented in this paper were conducted in a short period 
of a few days, where the external conditions of temperature and humidity were relatively constant. 
These may be considered overoptimistic testing conditions, since practical long-term testing of the 
device would involve changes in background conditions (temperature, humidity, and composition 
of ambient air) [53]. Implementation of the duty cycle mode for analogue MOX sensors is likely to 
improve long-term stability of the unit; however, this needs to be further investigated. The electronic 
circuit design also allows for further development of modulating approaches, for both the sensor and 
heater drives. 
5. Conclusions 
In this paper, we have shown the development and testing of a compact, IoT-enabled, portable 
E-nose for breath analysis, which deploys an array of 10 commercial MEMS MOX gas sensors. The 
functionality of the device was demonstrated with the testing of chemical standards (discriminating 
between acetone, isopropanol and 1-propanol) and a gas rig testing of isobutylene from 2–10 ppm, in 
2 ppm steps. PCA results indicate that the developed unit has some selectivity at distinguishing 
between individual chemicals. Gas rig testing results demonstrate that the sensor array consistently 
responded to the concentration steps. To further evaluate the developed system, the exhaled breath 
of 18 young male subjects was analysed before and after consuming a peppermint oil capsule. 
Classification analysis of exhaled breath samples demonstrates that we can distinguish between pre- 
and post-consumption of peppermint capsules with AUC: 0.81, sensitivity: 0.83 (0.59–0.96), 
specificity: 0.72 (0.47–0.90), p-value: <0.001. These results suggest that the unit can separate subject 
groups based on subtle changes in exhaled breath composition. It is our intention to deploy the unit 
in a UK hospital in an upcoming breath research study. 
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